Experts in heart failure clinical trials, including Scott Solomon and JoAnn Lindenfeld, discuss the importance of analyzing subgroups in trials. They emphasize the challenges in interpreting data, the impact of therapy, and the need for personalized medicine for better treatment outcomes.